![Frank Karbe](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 732 375 $ al 30/06/2026
Mr. Frank L.
Karbe is a Chief Financial & Accounting Officer at Cidara Therapeutics, Inc. and an Independent Director at Phathom Pharmaceuticals, Inc. He is on the Board of Directors at Phathom Pharmaceuticals, Inc. and Navigen, Inc. Mr. Karbe was previously employed as a President, CEO, Secretary & Treasurer by Better Therapeutics, Inc., an Independent Director by Aduro BioTech, Inc., a President, CFO & Chief Accounting Officer by Myovant Sciences Ltd., a President by Myovant Sciences, Inc., a President by The Color Run LLC, an Independent Director by Arbutus Biopharma Corp., a Chief Financial Officer & Executive Vice President by Exelixis, Inc., and a Vice President-Healthcare Group by Goldman Sachs & Co. He also served on the board at Kolltan Pharmaceuticals, Inc.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 19/05/2026 | 67.500 ( 0,08 % ) | 732 375 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| PHATHOM PHARMACEUTICALS, INC. | Director/Miembro de la Junta | 25/04/2022 |
| CIDARA THERAPEUTICS | Director Financiero/CFO | 24/02/2025 |
Navigen, Inc.
 Navigen, Inc. Pharmaceuticals: MajorHealth Technology Operates as a drug discovery and development company | Director/Miembro de la Junta | - |
| Empresas | Cargo | Fin |
|---|---|---|
| BETTER THERAPEUTICS, INC. | Director Ejecutivo | 14/03/2024 |
Myovant Sciences, Inc.
 Myovant Sciences, Inc. Medical SpecialtiesHealth Technology Develops therapeutics for women''s health and prostate cancer | Presidente | 12/08/2021 |
| MYOVANT SCIENCES LTD. | Director Financiero/CFO | 12/08/2021 |
| CHINOOK THERAPEUTICS, INC. | Director/Miembro de la Junta | 05/10/2020 |
| ARBUTUS BIOPHARMA CORPORATION | Director/Miembro de la Junta | 01/01/2018 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 12 |
|---|---|
Exelixis, Inc.
 Exelixis, Inc. Pharmaceuticals: MajorHealth Technology Operates as a cancer drug discovery company | Health Technology |
Arbutus Biopharma Corp.
 Arbutus Biopharma Corp. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics which targets viral diseases | Health Technology |
Aduro BioTech, Inc.
 Aduro BioTech, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company, which focuses on the development of technology platforms for cancer | Health Technology |
Kolltan Pharmaceuticals, Inc.
 Kolltan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures monoclonal antibody drugs | Health Technology |
Goldman Sachs & Co. LLC
 Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Navigen, Inc.
Navigen, Inc. Pharmaceuticals: MajorHealth Technology Operates as a drug discovery and development company | Health Technology |
Cidara Therapeutics, Inc.
 Cidara Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Engages in the discovery, development, and commercialization of novel anti-infectives | Health Technology |
Myovant Sciences, Inc.
Myovant Sciences, Inc. Medical SpecialtiesHealth Technology Develops therapeutics for women''s health and prostate cancer | Health Technology |
The Color Run LLC
 The Color Run LLC Movies/EntertainmentConsumer Services Operates as event management company | Consumer Services |
Myovant Sciences Ltd.
 Myovant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which provides women's health and prostate cancer solutions | Health Technology |
Phathom Pharmaceuticals, Inc.
 Phathom Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel treatments for gastrointestinal diseases and disorders | Health Technology |
Better Therapeutics, Inc.
 Better Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops prescription digital therapeutics for the treatment of cardiovascular and metabolic diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
